Care Pathway and Associated Costs of Patients Treated With CAR T-cells Based on SNDS Data

Inclusion Criteria

• •DLBCL population:
• •Patients with hospitalisation for CAR T-cell administration from 2017 to 2020 AND
• •Diagnosed with DLBCL (International Classification of Diseases \[ICD-10 C833\]) when receiving CAR-T AND
• •Being 18 years of age or older.
• •ALL population:
• •Patients with hospitalisation for CAR T-cell administration from 2017 to 2020 AND
• •Diagnosed with ALL (ICD-10 C910) when receiving CAR-T AND
• •Being 25 years of age or younger.